Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

DANBURY, Conn., July 16 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete, with the last study patient visit on July 14, 2008. Results of the full trial will be released either at Biodel's poster presentation at the European Association for the Study of Diabetes (EASD) on Tuesday, September 9, 2008, or at a later appropriate scientific forum.

Biodel also announced that two abstracts containing interim data from its VIAject(TM) Phase III clinical trials was posted on the Website for the 44th Annual Meeting of the EASD. The abstracts disclosed results of a January 2008 preliminary interim analysis of the secondary endpoints of dose, weight, and mild and moderate hypoglycemic events for the VIAject(TM) Phase III clinical trials.

"We continue to meet our timelines and are encouraged by the VIAject(TM) Phase III interim data, which continues to meet our expectations," stated Dr. Solomon Steiner, Chief Executive Officer and Chairman of Biodel. "We look forward to performing our final analysis and presenting data from the completed studies after the clinical trial database has been locked."

The interim analysis, dose and weight changes after six weeks of drug treatment were compared to the baseline for all patients who had completed six weeks or more of treatment. Additionally, total mild and moderate hypoglycemic events as of January 2008 were compared across the two treatment arms. The following additional information was reported in the EASD abstracts:

The interim results demonstrated statistically significant differences in weight changes in patients with Type 1 and Type 2 diabetes using VIAject(TM) compared to Humulin(R) R in the first six weeks of the study. Type 1 patients (n=102) receiving VIAject(TM) showed no change in weight compared to baseline, while a weight gain (1.4 +/- 2.9 kg) was seen in the patients (n=108) receiving Humulin(R
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , COLLEGE PARK, Md., Nov. 25 /PRNewswi...mpany developing a shaving cream-like foam that st...n the Most Promising Security Idea category of the... announce today. ,, Selected from more than 100...tched their invention at the GSC Security Summit c...
(Date:11/25/2009)..., , HARBIN, China, Nov. 25 /PRNew...c. ("China Sky One Medical" or "the Company") (Nas...tical company developing and producing,over-the-co...C"), today,announced that the Company recently pas... of Pharmaceutical and Biological Products ("ICPBP...
(Date:11/25/2009)..., , UNION CITY, Calif., Nov. 25 /PRNewswire...dical products company manufacturing point-of-care...t Severson, chairman and chief executive officer, ...th Care Conference on Wednesday, December 2, 2009 ...e New York Palace Hotel in New York City. ,, A...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Methodist Health System Selects Webmedx for Medical Transcription Technology and Services 56611 1Methodist Health System Selects Webmedx for Medical Transcription Technology and Services 56611 2National Preparedness Month Are You Prepared 3F 56609 1National Preparedness Month Are You Prepared 3F 56609 2National Preparedness Month Are You Prepared 3F 56609 3Nicotine Plays Tricks on Brain 3A Study 56607 1Nicotine Plays Tricks on Brain 3A Study 56607 2
...eath for Infants, WESTBOROUGH, Mass., April 14 G...ation (Nasdaq: GENZ ), announced,today that it is...roductive,testing to provide population carrier an...atrophy (SMA), the most common inherited cause of ...o are planning a pregnancy, or,who are already pre...
...ral Product Ganite(R), BERKELEY HEIGHTS, N.J., Ap...announced that the Company has received notice tha...ical gallium compositions,and complexes has been a...nt 7,354,952 extends the intellectual property sur...ontaining products that are intended,as potential ...
Other Medicine Technology:Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 2Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 3Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy 4Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3
(Date:11/26/2009)... living with diabetes will nearly double, increasi...34. Over the same period, spending on diabetes wil...billion, even with no increase in the prevalence o...Chicago report in the December issue of Diabetes ...ed by Medicare will rise from 8.2 million to 14.6 ...
(Date:11/26/2009)...ollercoaster, study finds , , THURSDAY, ...r meets the jubilant sports fan. , A new study ...oot for the winning team -- enjoy the greatest sat...ctory was in doubt, producing feelings of worry an...g weekend as you,re glued to the TV set, watching ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...SNewswire/ -- When most people hear the acronym TM...r can also give patients the help they need. TMJ s...where your jaw (mandible) contacts/connects with y...symptoms associated with TMJ dysfunction are pain ... many other symptoms can be caused from TMJ dysfun...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofMagnetic...entificInc.,aleadingproviderofsoftwareenablingtech...t4DAdvancedVisualizationsoftware. ,, Thisinnova...tbasedmedicalimagingofferinginthemarket.CalgarySci...taccess-requiringnosoftwaredownload,andrunsonanyMa...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...sue of the New England Journal of Medicine states ...ospitals with high-level neonatal intensive care ...ls care for more than 100 babies annually as compa...d the National Institutes of Health (agencies with...
... to be becoming ever more hectic. With the result ... Australian children in the 10-15 year age group t...h when compared with just one generation ago. ...hts out', says the University of South Australia's...
...roduced in England to ward-off people from heavy b...its and drink responsibly will be out by the end o...nisters and industry. The agreement was fi...ide by the agreement, legislation will be introduc...
... from the blood of bird flu survivors have helped ... virus. Scientists have long suspected that c...d provide a new therapy for the hard-to-treat H5N1...ditional way to treat or even prevent H5N1 in case...
...led that bricks made from fly-ash particles captur...afer than predicted. Rather than leach min...dicted, the bricks do the reverse, pulling minute ...ident of Freight Pipeline Company (FPC), which dev...
...mmed the tobacco industry for spreading untruths a...an increasing number of smoking bans around the w...s repeatedly "misled and misinformed the public ab..." Shigeru Omi, director of the WHO's Western Pacif...
Other Medicine News:Health News:High Level ICU Facilities Afford Greater Survival Chances for Small Infants 2Health News:High Level ICU Facilities Afford Greater Survival Chances for Small Infants 3Health News:Australian Children Sleep Less, Perhaps Not Well Monitored 2Health News:UK Introduce New Health Warnings Against Alcohol 2Health News:Blood from Bird Flu Survivors Provides Breakthrough in Treatment of H5N1 2Health News:Fly Ash Bricks are Absolutely Safer Than Actually Predicted 2Health News:WHO Condemns Tobacco Industry for Misleading Public 2
Epocrates Dx
PatientKeeper's Clinical Results
SJM Tailor Flexible Band
... Focus from Thermo Labsystems was designed specifi...rformance. Advanced features such as the new fast...microvolumes help to define this as a new leader i... handle plate offers a custom fit for different ha...
Medicine Products: